Your CDMO Partner for Successful Product & Project Results

At Biopharma Group, our primary focus is to deliver the highest standard of service, support, and products to our clients. With a customer-centric ethos and culture, we strive to meet the precise needs of your projects, regardless of their size or stage. Our mission is to augment your in-house expertise, ensuring successful outcomes every time.

Collaboration lies at the heart of our approach. By working closely with our clients, we gain a deeper understanding of their unique requirements, enabling us to provide tailored solutions to meet specific needs. We believe that by augmenting your team's capabilities, we can make each product project a resounding success.

Biopharma Group’s in-house lab with over 20 freeze dryers and specialist scientists makes it well-positioned to assist clients globally. Our extensive range of core services includes Contract R&D for lyo and liquid formulations, contract manufacturing services (non-GMP and GMP production), analytical services plus lyo instrumentation, and training courses. Let us delve into these offerings in detail.

CDMO Services:

Biopharma Group's R&D consultancy and lab analysis division was established in 1997 to provide unbiased contract research, analysis, and development services, as well as training and analytical instrumentation on an international scale. Our services have expanded to include contract manufacturing for lyophilization (lyo) and liquid formulations, which have proven particularly beneficial for the diagnostics and vaccines sectors. In addition, for more robust formulations that suit, we also offer spray drying and continue to evolve our offerings with a dedicated GMP facility (from Q4, 2023) and will be expanding our existing cyto and HPAPI suite 2023/2024.

We specialize in freeze-drying stages of product development, using either traditional lyocakes in vials or lyobeads processing for suitable products. Our contract R&D services cover pre- and post-lyophilization or spray drying testing, including pre-process comparable trial cycles to establish the best processing method for your product.

Benefits of Our Services:

By choosing Biopharma Group as your CDMO partner, you can benefit in numerous ways, including:

• Cost reductions: Proof of concept studies ensure that the best processing method is used for your desired results, increasing efficiency and reducing costs and batch rejections.
• Optimized cycles: Our expertise can significantly reduce cycle time, saving you valuable resources. Based on case studies, we have achieved time savings ranging from 2 to 5 days*.
• Saving time: We can help optimize your formulation, resulting in time savings of 60% to 80% through improved collapse temperature and reduced primary drying*.
• Reducing the percentage of rejections per cycle: Our services have led to significant reductions in rejection rates for customers, minimizing wastage and achieving rejection extents of less than 2% per batch*.
• Recovered efficiency in terms of cost and time: By optimizing processes, we have helped clients recover significant amounts, ranging from $30,000 to $50,000 for each day saved*.
• Extended shelf life: Products that have undergone long-term stability studies, have proved their stability for over 5 years, with shelf lives exceeding 24 months.

At Biopharma Group, our commitment to meeting your precise needs and ensuring project success sets us apart. With our wide range of services, regional divisions, and experienced scientists, we are ready to partner with you at every step of your journey. Trust us to augment your in-house expertise and achieve exceptional results. Contact us today to discuss your project requirements and explore how we can collaborate to bring your vision to life.